Edition:
United States

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

5.01USD
3:49pm EDT
Change (% chg)

$-0.10 (-2.05%)
Prev Close
$5.11
Open
$5.12
Day's High
$5.17
Day's Low
$4.99
Volume
81,769
Avg. Vol
304,451
52-wk High
$8.37
52-wk Low
$3.92

Select another date:

Thu, May 10 2018

BRIEF-Keryx Biopharmaceuticals Reports Q1 Loss Per Share Of $0.18

* KERYX BIOPHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Keryx Biopharmaceuticals Sees Total Revenue For Qtr Ended March 31, 2018 Between $21.0 Mln And $22.5 Mln

* KERYX BIOPHARMACEUTICALS SEES TOTAL REVENUE FOR QUARTER ENDED MARCH 31, 2018 OF BETWEEN $21.0 MILLION AND $22.5 MILLION - SEC FILING

BRIEF-Keryx Biopharmaceuticals Q4 Loss Per Share $0.26

* KERYX BIOPHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Keryx Biopharma Says Norwich Pharmaceuticals Agreed To Terminate Manufacturing Services Agreement

* KERYX BIOPHARMACEUTICALS- ON DEC 20,CO,NORWICH PHARMACEUTICALS AGREED TO TERMINATE MANUFACTURING SERVICES AGREEMENT BETWEEN CO,NPI,DATED JAN 17, 2014‍​

BRIEF-Biovectra And Keryx Biopharmaceuticals Enter Agreement For Ferric Citrate Production Expansion

* BIOVECTRA AND KERYX BIOPHARMACEUTICALS ENTER AGREEMENT FOR FERRIC CITRATE PRODUCTION EXPANSION

Select another date: